NCT00594815 Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Status COMPLETED Phase NA
NCT00591630 Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00590941 Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma Status COMPLETED Phase NA
NCT00589602 T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases Status TERMINATED Phase PHASE2
NCT00589563 Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer Status COMPLETED Phase PHASE2
NCT00589381 Fenretinide Lym-X-Sorb™ in Treating Patients With Recurrent or Resistant Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00588094 Dose Augmented Rituximab and ICE for Pts With Primary Refractory and Poor Risk Relapsed Aggressive B-Cell NHL Status COMPLETED Phase PHASE2
NCT00587015 A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) Status TERMINATED Phase PHASE1
NCT00586703 Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT Status COMPLETED Phase PHASE1
NCT00586690 Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT Status COMPLETED Phase PHASE1
NCT00583323 Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET Status COMPLETED Phase PHASE3
NCT00582621 Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders Status RECRUITING Phase N/A
NCT00580034 Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath Status COMPLETED Phase PHASE2
NCT00578942 Allo Non-myeloablative SCT Utilizing Matched Family Member Stem Cells Purged Using Campath Status COMPLETED Phase PHASE2
NCT00578461 T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE Status TERMINATED Phase NA
NCT00577993 Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients Status COMPLETED Phase PHASE3
NCT00577798 Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin Status COMPLETED Phase N/A